Recombinant multi-species EPX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the peroxidase gene family and is expressed in eosinophils. The encoded preproprotein is proteolytically processed into covalently attached heavy and light chains to form the mature enzyme, which functions as an oxidant. The enzyme is released at sites of parasitic infection or allergen stimulation to mediate lysis of protozoa or parasitic worms. The gene is found in a gene cluster with other peroxidase genes on chromosome 17. Mutations in this gene result in eosinophil peroxidase deficiency. [provided by RefSeq, Feb 2016]
The Alternative Names of target: EPO,EPP,EPX,EPX-PEN,EPXD,Eosinophil peroxidase,Epx
Go
to EPX products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T42319-Ag-1/ GM-Tg-hg-T42319-Ag-2 | Human EPX protein | Human |
| GM-Tg-rg-T42319-Ag-1/ GM-Tg-rg-T42319-Ag-2 | Rat EPX protein | Rat |
| GM-Tg-mg-T42319-Ag-1/ GM-Tg-mg-T42319-Ag-2 | Mouse EPX protein | Mouse |
| GM-Tg-cynog-T42319-Ag-1/ GM-Tg-cynog-T42319-Ag-2 | Cynomolgus/Rhesus macaque EPX protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T42319-Ag-1/ GM-Tg-felg-T42319-Ag-2 | Feline EPX protein | Feline |
| GM-Tg-cang-T42319-Ag-1/ GM-Tg-cang-T42319-Ag-2 | Canine EPX protein | Canine |
| GM-Tg-bovg-T42319-Ag-1/ GM-Tg-bovg-T42319-Ag-2 | Bovine EPX protein | Bovine |
| GM-Tg-equg-T42319-Ag-1/ GM-Tg-equg-T42319-Ag-2 | Equine EPX protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T42319-Ag-1/ GM-Tg-hg-T42319-Ag-2;
GM-Tg-rg-T42319-Ag-1/ GM-Tg-rg-T42319-Ag-2;
GM-Tg-mg-T42319-Ag-1/ GM-Tg-mg-T42319-Ag-2; GM-Tg-cynog-T42319-Ag-1/ GM-Tg-cynog-T42319-Ag-2; GM-Tg-felg-T42319-Ag-1/ GM-Tg-felg-T42319-Ag-2; GM-Tg-cang-T42319-Ag-1/ GM-Tg-cang-T42319-Ag-2; GM-Tg-bovg-T42319-Ag-1/ GM-Tg-bovg-T42319-Ag-2; GM-Tg-equg-T42319-Ag-1/ GM-Tg-equg-T42319-Ag-2 |
| Products Name | EPX protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | EPX |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EPX protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.